The contribution of SVZ precursors to corpus callosum remyelination has been addressed in the EAE model of MS [9] and after toxic demyelination, using in vivo genetic fate mapping [13], single-cell tracking with β-actin GFP [11] and retroviral GFP injections [49]. Here, ACTB is linked to myeloid sarcoma.